Medicure (MCUJF) Research & Development (2009 - 2026)

Medicure's Research & Development history runs 18 years deep, the most recent figure standing at $623470.9 for Q1 2026.

• On a quarterly basis, Research & Development rose 56.95% year-over-year to $623470.9 in Q1 2026; TTM through Mar 2026 was $2.5 million, a 16.72% increase from a year earlier, with the FY2025 full-year figure at $2.3 million, up 1.11% from the prior year.
• Research & Development declined to $623470.9 in Q1 2026 per MCUJF's latest filing, from $825366.3 in the prior quarter.
• Across five years, Research & Development topped out at $1.5 million in Q3 2022 and bottomed at -$567998.0 in Q4 2022.
• The 5-year median for Research & Development is $520997.3 (2025), against an average of $447504.8.
• Across the five-year window, Research & Development sank 242.85% in 2023 and surged 228.94% in 2024, its largest moves.
• Year by year, Research & Development stood at -$567998.0 in 2022, then advanced by 0.29% to -$566326.9 in 2023, then surged by 193.79% to $531160.1 in 2024, then soared by 55.39% to $825366.3 in 2025, then declined by 24.46% to $623470.9 in 2026.
• Per Business Quant, the three latest MCUJF Research & Development figures stand at $623470.9 (Q1 2026), $825366.3 (Q4 2025), and $520997.3 (Q3 2025).